Fundraising Fox
Rory Riggs
InvestorFounderGeneral Partner at Scientia Ventures · Chairman of the Board at Cibus
FoundedCibus
Find your path to Rory
Sign up to see every warm intro you have to Rory
- Paths you didn't know you had: your email and LinkedIn already hold routes to Rory. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Rory Riggs has worked in the biotechnology industry for over 25 years as an entrepreneur, executive, and investor. He co-founded and served as chairman or director of companies including Royalty Pharma, Fibrogen, Sugen, GeneNews, and Cibus, and was president and director of Biomatrix Corporation, where he launched the osteoarthritis treatment Synvisc. He is currently founder and CEO of Locus/Syntax, applying attribute-based data analytics to finance and economics, and was a co-founder of Scientia Ventures' predecessor, New Venture Funds. He holds a BA from Middlebury College and an MBA from Columbia University.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Chairman of the Board at Cibus
Intro paths
In turn, Rory can intro founders to Cibus's investors below.
Cibus's investors · 2
Co-founders at Cibus
Deals · 1
GenenewsBoard seat
via Scientia Ventures · filed Feb 2022 · $7.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sources: SEC Form D filings · the firm's website.
Colleagues at Scientia Ventures
Frequently asked questions
- Who is Rory Riggs?
- Rory Riggs has worked in the biotechnology industry for over 25 years as an entrepreneur, executive, and investor. He co-founded and served as chairman or director of companies including Royalty Pharma, Fibrogen, Sugen, GeneNews, and Cibus, and was president and director of Biomatrix Corporation, where he launched the osteoarthritis treatment Synvisc. He is currently founder and CEO of Locus/Syntax, applying attribute-based data analytics to finance and economics, and was a co-founder of Scientia Ventures' predecessor, New Venture Funds. He holds a BA from Middlebury College and an MBA from Columbia University.
- Where does Rory Riggs work?
- Rory Riggs is Chairman of the Board of Cibus and General Partner at Scientia Ventures.
- What does Rory Riggs invest in?
- Rory Riggs invests in Biotech, Healthtech.
- What companies did Rory Riggs found?
- Rory Riggs founded Cibus.
- What boards does Rory Riggs sit on?
- Rory Riggs holds tracked board seats at Cibus, Cibus, eReceivables, Fibrogen, Genenews, Genenews, GeneNews, Royalty Pharma, Sugen.
Founder mafias
Fibrogen mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Scientia Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights